The world’s first CAR-T therapy for solid tumors has passed muster in China, with the country's National Medical Products ...

Amid efforts in Germany to retool the country’s drug spending, the U.S. is launching an investigation into what the Office of ...

The ruling marks the end of a case that put Alnylam and Pfizer at loggerheads. In its response to the PMCPA, Alnylam accused ...

AbbVie and Johnson & Johnson are the current big spenders when it comes to TV drug ads in the U.S., but Eli Lilly and Novo ...

Pharma companies have been part of the global economy and our health systems for centuries. | Pharma companies have been part ...

A deviation gets flagged on a 2,000-liter batch. The product sits on hold until someone can explain what happened and whether ...

After disclosing a security breach last week concerning “a limited number of internal IT systems,” details on the cyber ...

As it prepares to launch up to three new products from 2027 through 2028, Moderna is adjusting its way of doing business.  | ...

Four years after Spero Therapeutics received a complete response letter from the FDA, rejecting its oral treatment for ...

Before Indian drugmaker Aurobindo can complete its acquisition of Pennsylvania generics specialist Lannet, it will have to ...

With pharma and life sciences deal values surpassing $65 billion in Q1, marking the strongest quarter in the industry since ...

Merck & Co.’s first-in-class HIF-2 alpha inhibitor Welireg is touching down in the clear cell renal cell carcinoma (ccRCC) | ...